Mario Gabelli Cognition Therapeutics Inc Transaction History
Gamco Investors, Inc. Et Al
- $9.45 Billion
- Q3 2025
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 20,000 shares of CGTX stock, worth $31,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$31,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
76Shares Held
23MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$9.3 Million9.11% of portfolio
-
Davenport & CO LLC2.69MShares$4.17 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$4.16 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.42 Million0.02% of portfolio
-
Tang Capital Management LLC San Diego, CA1.2MShares$1.86 Million0.07% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $35.2M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...